
Northrop Grumman (NOC) just put its FORTITUDE gallium nitride chip on the table, a grain sized component that processes wide swaths of the electromagnetic spectrum for satellites, radar, GPS and future 6G systems.
Recent trading tells a different story to the technology headlines. Northrop Grumman’s share price has fallen 17.51% year to date and the 1 year total shareholder return is down 21.02%, even though the 5 year total shareholder return of 34.32% points to much steadier long run compounding.
Spot 91 AI infrastructure stocks that, like Northrop Grumman’s FORTITUDE chip, aim to power the next wave of satellites, defense systems, and ultra-fast wireless connectivity.Northrop Grumman now trades well below both analyst targets and some intrinsic value estimates after that share price slide. Is this a discount on misunderstood potential, or a fair warning label on execution and program risk?
Northrop Grumman last closed at $483.11, while the most widely followed thesis centers on a fair value of $646.41, built using an 8.38% discount rate and program level cash flow assumptions.
Expansion of munitions and solid rocket motor capacity, supported by 10 multi year missile acceleration agreements worth up to US$10b over seven years, including a US$2b PAC 3 framework, positions Northrop Grumman to convert this pipeline into higher sales and potentially improved margins as volumes scale.
See why 110 investors see Northrop Grumman as 25% undervalued.
Result: Fair Value of $646.41 (UNDERVALUED)
Still, the Northrop Grumman story can unravel if cost overruns on complex fixed price programs persist or if heavy capital spending fails to translate into profitable contracts.
Find out about the key risks to this Northrop Grumman narrative.
Mixed sentiment runs through this Northrop Grumman story, so move quickly, review the underlying data, and weigh both the 4 key rewards and 1 important warning sign.
If Northrop Grumman has your attention, do not stop here. Use the Simply Wall Street Screener to uncover other opportunities that might fit your playbook.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com